Different Application Rates of Crisaborole Ointment 2% in Adults With Mild to Moderate Atopic Dermatitis
Status:
Completed
Trial end date:
2020-11-25
Target enrollment:
Participant gender:
Summary
This study is being conducted to evaluate the efficacy and safety of 3 different application
rates of topically applied Crisaborole ointment 2% over vehicle in adults with mild to
moderate atopic dermatitis (AD). In each subject four application areas will be identified.
Each subject will receive 4 treatments: the 3 different application rates of the active
treatment and the vehicle. The areas will be randomly assigned to treatment with topical
Crisaborole ointment 2% and vehicle, once daily, for 2 weeks, without occlusion.